Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Oct 24, 2018
Clínica Universidad de Navarra is the only center to start clinical trials with the new therapy designed for adult patients with recurrent glioblastoma. The new type of genetically modified virus has been developed by DNAtrix Inc. (USA) and designed by the laboratory of doctors Juan Fueyo and Candelaria Gómez-Manzano at the MD Anderson Cancer Center in Houston (USA).